202 related articles for article (PubMed ID: 15192787)
1. Serum and bile markers for cholangiocarcinoma.
Nehls O; Gregor M; Klump B
Semin Liver Dis; 2004 May; 24(2):139-54. PubMed ID: 15192787
[TBL] [Abstract][Full Text] [Related]
2. [Tumor markers in the diagnosis of tumors in the subhepatic area].
Dufek V; Petrtýl J; Klener P; Chmel J
Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
5. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
Lempinen M; Isoniemi H; Mäkisalo H; Nordin A; Halme L; Arola J; Höckerstedt K; Stenman UH
J Hepatol; 2007 Nov; 47(5):677-83. PubMed ID: 17640760
[TBL] [Abstract][Full Text] [Related]
6. [Cholangiocarcinoma--bile ducts cancer].
Dubaniewicz A; Dubaniewicz A
Wiad Lek; 2003; 56(1-2):57-60. PubMed ID: 12901270
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma: risk factors, diagnosis and management.
Acalovschi M
Rom J Intern Med; 2004; 42(1):41-58. PubMed ID: 15529594
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical analysis for cholangiocarcinoma].
Nakagoe T; Matsuo T; Kondoh M; Yamaguchi H
Nihon Rinsho; 2006 Jan; 64 Suppl 1():370-4. PubMed ID: 16457285
[No Abstract] [Full Text] [Related]
9. The value of biliary fibronectin for diagnosis of cholangiocarcinoma.
Chen CY; Lin XZ; Tsao HC; Shiesh SC
Hepatogastroenterology; 2003; 50(52):924-7. PubMed ID: 12845951
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma.
Patel T
Nat Clin Pract Gastroenterol Hepatol; 2006 Jan; 3(1):33-42. PubMed ID: 16397610
[TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
12. Management of combined hepatocellular and cholangiocarcinoma.
Kassahun WT; Hauss J
Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443
[TBL] [Abstract][Full Text] [Related]
13. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.
Albiin N; Smith IC; Arnelo U; Lindberg B; Bergquist A; Dolenko B; Bryksina N; Bezabeh T
Acta Radiol; 2008 Oct; 49(8):855-62. PubMed ID: 18608012
[TBL] [Abstract][Full Text] [Related]
14. Distal biliary malignancy.
Veillette G; Castillo CF
Surg Clin North Am; 2008 Dec; 88(6):1429-47, xi. PubMed ID: 18992603
[TBL] [Abstract][Full Text] [Related]
15. [Cathepsin B-like substance in the monitoring of chemically induced primary cholangiocarcinoma in swine].
Dufek V; Petrtýl J; Klener P
Vnitr Lek; 1996 Aug; 42(8):551-4. PubMed ID: 8967025
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
Bickenbach K; Galka E; Roggin KK
Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
[TBL] [Abstract][Full Text] [Related]
17. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.
Li YG; Zhang N
Dig Liver Dis; 2009 Aug; 41(8):605-8. PubMed ID: 19168405
[TBL] [Abstract][Full Text] [Related]
19. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.
Matsuda A; Kuno A; Kawamoto T; Matsuzaki H; Irimura T; Ikehara Y; Zen Y; Nakanuma Y; Yamamoto M; Ohkohchi N; Shoda J; Hirabayashi J; Narimatsu H
Hepatology; 2010 Jul; 52(1):174-82. PubMed ID: 20578261
[TBL] [Abstract][Full Text] [Related]
20. Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma.
Wang X; Dai S; Zhang Z; Liu L; Wang J; Xiao X; He D; Liu B
Eur J Cancer Care (Engl); 2009 Nov; 18(6):625-35. PubMed ID: 19486127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]